Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tibetan Medicine and Remote Ischemic Conditioning for High Altitude Polycythemia
NCT06082583Phase 3Not yet recruiting
- Sponsor
- Capital Medical University
- Start
- Nov 2023
- Primary completion
- Dec 2025
01
Overview
Phase 3, randomised trial (2 arms), sponsored by Capital Medical University. Primary endpoint: Incidence of effective treatment. Planned start Nov 2023; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06082583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06082583.